 | Up a level |
Number of items: 2.
Wilding, JPH 
ORCID: 0000-0003-2839-8404, Godec, T, Khunti, K, Pocock, S, Fox, R, Smeeth, L, Blak, B, Clauson, P, Fenici, P, Hammar, N et al (show 2 more authors)
(2017)
Changes in HbA(1c) and weight after initiation of second-line therapy in patients with type 2 diabetes in clinical practice.
.
Wilding, J ORCID: 0000-0003-2839-8404, Bailey, C, Rigney, U, Blak, B, Kok, M and Emmas, C
(2017)
Dapagliflozin therapy for type 2 diabetes in primary care: Changes in HbA1c, weight and blood pressure over 2 years follow-up.
PRIMARY CARE DIABETES, 11 (5).
pp. 437-444.